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Sumeet Subherwal, MD, MBA,*† Judith Stafford, MS,* Sarah Calhoun, BS,*
Eric D. Peterson, MD, MPH*†
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Objectives This study sought to characterize temporal trends, patient-specific factors, and geographic variation associated
with amputation in patients with lower-extremity peripheral artery disease (LE PAD) during the study period.
Background Amputation represents the end-stage failure for those with LE PAD, and little is known about the rates and geo-
graphic variation in the use of LE amputation.
Methods By using data from the Centers for Medicare & Medicaid Services (CMS) from January 1, 2000, to December 31,
2008, we examined national patterns of LE amputation among patients age 65 years or more with PAD. Multi-
variable logistic regression was used to adjust regional results for other patient demographic and clinical factors.
Results Among 2,730,742 older patients with identified PAD, the overall rate of LE amputation decreased from 7,258
per 100,000 patients with PAD to 5,790 per 100,000 (p  0.001 for trend). Male sex, black race, diabetes mel-
litus, and renal disease were all independent predictors of LE amputation. The adjusted odds ratio of LE amputa-
tion per year between 2000 and 2008 was 0.95 (95% CI: 0.95–0.95, p  0.001).
Conclusions From 2000 to 2008, LE amputation rates decreased significantly among patients with PAD. However, there re-
mains significant patient and geographic variation in amputation rates across the United States. (J Am Coll
Cardiol 2012;60:2230–6) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.08.983Lower-extremity peripheral artery disease (LE PAD) is a
prevalent disorder that affects approximately 8 million
Americans (1). In its end stage, patients with severe PAD
can require LE amputation (2). LE amputation is associated
with significant morbidity, mortality, and healthcare costs
(3,4). Over the past decade, treatment strategies for those
with PAD have improved, including better early detection,
more frequent referral for diagnostic imaging, and improved
revascularization options. Combined, these may have sig-
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accepted August 21, 2012.nificantly reduced the need for LE amputation, yet no
national studies have summarized these changes. In addi-
tion, treatment of PAD often differs regionally (5–7), and it
remains unclear whether geographic variation may further
contribute to the risk of LE amputation. Consequently, we
performed an analysis of the U.S. Medicare data to provide
a more contemporary report of national temporal and
geographic trends in amputation. Our specific aims were to:
1) characterize temporal trends in LE amputation during the
study period; 2) examine patient factors that were associated
with LE amputation; and 3) determine whether there was
geographic variation in LE amputation across the United
States.
Methods
Data sources. We obtained the 100% inpatient Medicare
standard analytic files and corresponding denominator files
from the Centers for Medicare & Medicaid Services (CMS)
for January 1, 2000, to December 31, 2008. The inpatient
files contain institutional claims for facility costs covered
under Medicare Part A. The denominator files contain
beneficiary demographic and clinical characteristic data. We
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November 20/27, 2012:2230–6 Lower-Extremity Amputation in Medicare Patientsrestricted the study population to those patients with
fee-for-service Medicare Parts A and B enrollment at the
index admission and censored patients if they switched to
managed care and/or dropped Medicare Part A or B.
Identification of patients. We identified beneficiaries for
whom an International Classification of Diseases-Ninth
Revision-Clinical Modification [ICD-9-CM] diagnosis
code or procedure code for LE PAD was reported during
the study period (Online Appendix 1). We also identified
beneficiaries who underwent a first major LE amputation
(as defined by above-knee or below-knee amputation, not
including transmetatarsal or foot amputations) during the
study period as those for whom an ICD-9-CM procedure
code (84.13 to 84.18) for above-knee or below-knee ampu-
tation was reported. In subjects who underwent multiple LE
amputations, those that occurred after the index major
amputation were not included in the analysis.
Patient characteristics. Patient demographic characteris-
tics included age, sex, race, state of residence, and ZIP code
of residence. Medicare beneficiaries report race at the time
of enrollment. We used previously validated methods to
identify comorbid conditions using ICD-9-CM billing claims
for up to 5 years before the index hospitalization (8). We used
he patient’s state of residence to group beneficiaries into 9 U.S.
ensus Bureau regions (Online Appendix 2) (6,7).
tatistical analysis. We present categoric variables as fre-
uencies with percentages and continuous variables as
eans with standard deviations. To test for differences
etween groups, we used the Pearson chi-square test for
ategoric variables and the Wilcoxon ranksum test for
ontinuous variables. We calculated the annual rates of
ower-extremity amputation, the annual rates of hospital-
zation and amputation from 2000 to 2008, and the ratio
f amputation in each state to the national rates and
apped these ratios. To determine whether geographic
ariation was associated with amputation, we performed
ultivariable logistic regression adjusting for clinical
ariables (age, sex, race, and comorbid conditions, in-
luding diabetes mellitus, renal disease, congestive heart
ailure, and cerebrovascular disease) and further adjusting
or index year and geographic variation within the model.
dds ratios (ORs) and 95% confidence intervals (CIs) are
resented for LE amputation.
The Duke University Institutional Review Board re-
iewed and approved this study design. We used SAS
tatistical software, version 9.2 (SAS Institute Inc., Cary,
orth Carolina) for all analyses.
esults
atient characteristics. There were approximately 3 mil-
ion Medicare beneficiaries hospitalized for PAD from 2000
o 2008. A total of 186,338 patients (6.8% of the overall
ospitalized population with PAD) underwent LE ampu-
ation during the study period. Table 1 shows the demo-
raphic and clinical characteristics of all Medicare bene- tciaries who were hospitalized
or PAD and the characteristics
f those with and without LE
mputation during the study
eriod.
Among beneficiaries who un-
erwent major LE amputation,
pproximately 65% were 75
ears old, approximately one-half
ere men, and one-quarter were
lack. Patients with PAD who
nderwent amputation were
ore likely to be black (28.1%
s. 9.5%, p  0.001), to have
iabetes mellitus (60.3% vs.
5.7%, p  0.001), and to have
enal disease (29.5% vs. 15.5%, p  0.001) when com-
ared with patients with PAD who did not undergo an
mputation.
Table 2 shows the results of logistic regression models
reated to show the clinical predictors of LE amputation.
en, African Americans, and the presence of diabetes and
enal disease were clinical and demographic variables inde-
endently associated with LE amputation, whereas coronary
rtery disease and cancer were associated with reduced risk
f LE amputation.
emporal trends in PAD treatment and LE amputation.
rom 2000 to 2008, the overall use of LE amputation
ecreased significantly during the study period (7,258 to
,790 LE amputations per 100,000 Medicare beneficiaries
ith PAD, p  0.001; Table 3). Table 3 also shows the
emporal trends in LE amputation over the study period
total, above knee, below knee). The adjusted OR of LE
mputation per year after 2000 was 0.95 (95% CI: 0.95 to
.95, p  0.001) (Table 2).
eographic variation. There was significant geographic
ariation in the rate of lower-extremity amputation from
,400 amputations per 100,000 patients with PAD in the
ast South Central region to 5,500 amputations per
00,000 patients with PAD in the Mountain region.
igure 2 shows the rate of amputation per the U.S. Census
ureau during the study period.
Geographic variation continued to be independently as-
ociated with LE amputation after adjusting for clinical
ariables and temporal trends in the multivariable model.
ven after adjusting for clustering at the U.S. Census
ureau level, geographic variation in LE amputations re-
ained. LE amputation was performed more often in the
ast South Central region (adjusted OR: 1.152, 95% CI:
.131 to 1.174, p  0.001) and West South Central region
adjusted OR: 1.115, 95% CI: 1.097 to 1.133, p  0.001),
nd less often in the Middle Atlantic region (OR: 0.833,
5% CI: 0.820 to 0.847, p  0.001) when compared with
Abbreviations
and Acronyms
CI  confidence interval
CMS  Centers for
Medicare & Medicaid
Services
HRR  hospital referral
region
ICD-9-CM  International
Classification of Diseases,
Ninth Revision, Clinical
Modification
LE PAD  lower-extremity
peripheral artery disease
OR  odds ratiohe South Atlantic region as reference (Table 2).
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The primary findings from this cohort study of elderly
Medicare beneficiaries with PAD are that there has been a
marked reduction in LE amputations within the United
States. Between 2000 and 2008, the overall annual rates of
LE amputation significantly decreased from 7,258 to 5,790
per 100,000 patients with PAD. Second, there remains
significant geographic variation. Rates of LE amputation
were generally higher in the East South Central, West
South Central, and South Atlantic regions, whereas the
Mountain, New England, and West North Central regions
had lower rates (Fig. 1). Of note, geographic variation
remained statistically associated with LE amputation after
adjustment for clinical factors.
There are multiple potential explanations for the dra-
matic decrease in the number of LE amputations observed
in the current study. First, the importance of prevention of
LE amputation and emphasis on early screening and detec-
Demographic and Clinical CharacteristicsTable 1 Demographic and Clinical Characte
Overall
(N  2,730,742)
PAD
Age, yrs 77.4 7.6
Age, yrs
65–69 490,087 (17.9)
70–74 559,312 (20.5)
75–79 627,886 (23.0)
80 1,053,457 (38.6)
Male 1,352,662 (49.5)
Race
White 2,342,742 (85.8)
Black 293,285 (10.7)
Asian 17,483 (0.6)
Other 77,232 (2.8)
U.S. geographic region
New England 132,094 (4.8)
Middle Atlantic 406,576 (14.9)
South Atlantic 595,493 (21.8)
East North Central 525,337 (19.2)
East South Central 217,045 (7.9)
West North Central 195,749 (7.2)
West South Central 333,659 (12.2)
Mountain 104,083 (3.8)
Pacific 220,706 (8.1)
Comorbidities
Cancer 236,135 (8.6)
Cerebrovascular disease 436,161 (16.0)
Congestive heart failure 987,779 (36.2)
Chronic obstructive pulmonary
disease
973,553 (35.7)
Coronary artery disease 1,674,727 (61.3)
Dementia 97,360 (3.6)
Diabetes mellitus 1,021,469 (37.4)
Hypertension 2,107,597 (77.2)
Renal disease 448,747 (16.4)
Values are mean  SD or n (%).tion of vascular disease in patients at risk for LE amputationmay be contributing to the decline in amputation rates
(9,10). Second, studies of revascularization procedures in
patients with PAD have consistently shown that the use of
endovascular revascularization has increased significantly
after 2000 and when combined with improved screening
and detection methods may contribute to the decline in
amputation rates (11). In the current study, we used the Part
A Medicare dataset that captured inpatient billing claims,
and because of this, we were unable to fully explore the use
of screening tests and revascularization procedures, some of
which may be performed more frequently on an outpatient
basis. The national shift to outpatient care and procedures
in cardiovascular medicine is unlikely to affect the measure-
ment of major LE amputations, such as above-knee and
below-knee amputations, but it may be possible for ray
amputations.
When studying the effect of geographic variation, prior
work from Medicare beneficiaries with diabetic foot ulcers
s
ut LE Amputation
2,544,404)
PAD With LE Amputation
(N  186,338) p Value
7.3 7.5 78.5 8.2 0.001
9,538 (18.1) 30,549 (16.4) 0.001
4,965 (20.6) 34,347 (18.4) 0.001
9,502 (23.2) 38,384 (20.6) 0.001
0,399 (38.1) 83,058 (44.6) 0.001
3,035 (49.6) 89,627 (48.1) 0.001
7,917 (87.2) 124,825 (67.0) 0.001
0,874 (9.5) 52,411 (28.1) 0.001
6,417 (0.6) 1,066 (0.6) 0.001
9,196 (2.7) 8,036 (4.3) 0.001
4,789 (4.9) 7,305 (3.9) 0.001
1,189 (15.0) 25,387 (13.6) 0.001
0,437 (21.6) 45,056 (24.2) 0.001
4,627 (19.4) 30,710 (16.5) 0.001
8,798 (7.8) 18,247 (9.8) 0.001
4,858 (7.3) 10,891 (5.8) 0.001
6,032 (12.0) 27,627 (14.8) 0.001
8,350 (3.9) 5,733 (3.1) 0.001
5,324 (8.1) 15,382 (8.3) 0.005
3,021 (8.8) 13,114 (7.0) 0.0001
8,865 (15.3) 47,296 (25.4) 0.001
5,135 (35.2) 92,644 (49.7) 0.001
7,824 (35.7) 65,729 (35.3) 0.001
1,028 (61.7) 103,699 (55.7) 0.001
9,930 (3.1) 17,430 (9.4) 0.001
9,131 (35.7) 112,338 (60.3) 0.001
8,113 (77.0) 149,484 (80.2) 0.001
3,778 (15.5) 54,969 (29.5) 0.001ristic
Witho
(N 
7
45
52
58
97
1,26
2,21
24
1
6
12
38
55
49
19
18
30
9
20
22
38
89
90
1,57
7
90
1,95
39has proposed that the risk of LE amputation is more an
Factors Associated With Lower-Extremity AmputationTable 2 Factors Associated With Lower-Extremity Amputation
Effect
Unadjusted Adjusted
OR: Estimate
Lower 95%
Confidence
Limit for OR
Upper 95%
Confidence
Limit for OR Chi-Square p Value OR: Estimate
Lower 95%
Confidence
Limit for OR
Upper 95%
Confidence
Limit for OR Chi-Square p Value
Geographic and temporal factors
East North Central 0.76 0.75 0.77 1,303.5 0.001 0.83 0.82 0.84 546.7 0.001
East South Central 1.12 1.10 1.14 157.0 0.001 1.15 1.13 1.17 220.3 0.001
Middle Atlantic 0.81 0.80 0.83 644.3 0.001 0.83 0.82 0.85 467.4 0.001
Mountain 0.71 0.69 0.73 552.0 0.001 0.96 0.94 0.99 6.5 0.011
New England 0.72 0.70 0.73 664.8 0.001 0.89 0.86 0.91 82.9 0.001
Pacific 0.92 0.90 0.93 83.6 0.001 1.02 1.00 1.04 3.7 0.056
West North Central 0.72 0.70 0.74 891.2 0.001 0.92 0.90 0.94 61.4 0.001
West South Central 1.10 1.09 1.12 151.5 0.001 1.12 1.10 1.13 171.3 0.001
South Atlantic (Reference) 1.00 1.00 1.00 1.00 1.00 1.00
Year (per 1-yr increase) 0.97 0.96 0.97 1,325.4 0.001 0.95 0.95 0.95 2,565.9 0.001
Clinical factors
Race: black vs. white 2.90 2.83 2.90 29,606.2 0.001
Diabetes mellitus 2.40 2.38 2.43 27,639.2 0.001
Renal disease 1.63 1.61 1.65 6,614.3 0.001
Dementia 2.09 2.05 2.13 5,958.5 0.001
Coronary artery disease 0.67 0.66 0.68 5,724.8 0.001
Age (per 5-yr increase) 1.13 1.13 1.14 5,659.2 0.001
Congestive heart failure 1.47 1.46 1.49 4,963.9 0.001
Cerebrovascular disease 1.49 1.47 1.50 4,315.7 0.001
Race: other vs. white 1.52 1.49 1.56 1,102.3 0.001
Male 1.14 1.13 1.15 655.1 0.001
Cancer 0.82 0.80 0.83 438.5 0.001
Hypertension 0.92 0.91 0.93 156.4 0.001
COPD 1.03 1.02 1.04 30.9 0.001
Race: Asian vs. white 0.89 0.83 0.95 13.1 0.001
COPD  chronic obstructive pulmonary disease; OR  odds ratio.
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Lower-Extremity Amputation in Medicare Patients November 20/27, 2012:2230–6effect of the location of a hospital referral region (HRR)
rather than the HRR itself (12). This report found that
spatial clustering was present, in other words, that higher
LE amputation rates in HRRs were more likely in the
presence of nearby HRRs with high LE amputation rates
rather than in nearby HRRs with lower LE amputation
rates. Given the clustering of regions with a higher risk of
LE amputation in the current study, this suggests that
similar, unmeasured effects of socioeconomic status, access
to care, and application of care may contribute to the risk of
LE amputation in patients with PAD. In addition, the
timing of patient presentation for evaluation of patients
with rest leg pain or ischemic ulceration may vary, and
Rate of Lower-Extremity Amputations per U.S. Census Bureau DuriTable 3 Rate of Lower-Extremity Amputations per U.S. Census
2000 2001 200
Total no. of LE amputations per 100,000
patients with PAD
7,258 7,525 7,35
No. of LE amputations above knee per
100,000 patients with PAD
4,155 4,286 4,21
No. of LE amputations below knee per
100,000 patients with PAD
3,104 3,239 3,14
East North Central 6,511 6,608 6,27
East South Central 8,268 9,202 9,26
Middle Atlantic 6,295 6,906 6,65
Mountain 6,134 6,394 6,27
New England 6,484 6,529 5,52
Pacific 7,270 7,368 7,69
South Atlantic 7,959 7,995 8,10
West North Central 5,934 6,230 5,99
West South Central 9,237 9,339 8,91
All values are reported as number of LE amputations per 100,000 patients with PAD.
LE  lower extremity; PAD  peripheral artery disease.
Figure 1 Geographic Variation in Use of Lower-Extremity Ampu
Geospatial map showing the ratio of rates of LE amputation per state compared wunderscores the importance of patient education and aware-
ness in those at highest risk for LE amputation. Finally, the
threshold to perform LE amputation differs among provid-
ers, and therefore further exploration of the presence of
vascular specialists per region and the presence of integrated
vascular care specialty centers may help explain some of the
variation in our study. Regardless of these factors, this
variation highlights the importance of programs to educate
patients and providers in the areas with the highest use of
LE amputation.
The study findings provide focus for areas of further
research. Analyses are needed to determine whether hospital
and provider characteristics contributed to the observed
udy Periodau During Study Period
2003 2004 2005 2006 2007 2008
7,091 6,919 6,580 6,072 6,000 5,790
4,034 3,977 3,800 3,540 3,484 3,312
3,057 2,942 2,780 2,532 2,517 2,478
5,949 5,791 5,570 5,141 4,893 5,043
8,753 8,797 8,146 7,359 7,565 7,591
6,631 6,456 5,992 5,550 5,781 5,269
5,663 5,182 5,188 4,616 4,575 5,052
5,668 5,267 5,094 4,745 4,658 5,006
7,185 7,289 6,801 6,767 6,189 5,655
7,973 7,779 7,468 6,884 6,789 6,198
5,530 5,606 5,511 4,792 5,035 4,804
8,636 8,256 7,853 7,251 7,085 6,874
national average. LE  lower extremity.ng StBure
2
9
6
2
6
1
9
5
5
2
2
6
9tation
ith the
2235JACC Vol. 60, No. 21, 2012 Jones et al.
November 20/27, 2012:2230–6 Lower-Extremity Amputation in Medicare Patientsgeographic variation. Further research also is needed in
understanding “best practices” and features associated with
low amputation regions and areas with significant reduc-
tions in amputations over the study period. In fact, a recent
analysis from Medicare Part B data reported a significant
variation in the intensity of diagnostic angiography, endo-
vascular revascularization, and surgical revascularization in
the year preceding LE amputation, potentially providing
some early insights into practice patterns (5).
Study limitations. The current study has multiple limita-
tions. First, Medicare claims data do not include informa-
tion regarding PAD duration or progression of symptoms,
severity and burden of disease, and patients and physician
treatment preferences that may affect the decision to per-
form amputation and the rates of amputation. Second,
patients without a definitive diagnosis of PAD who under-
went amputation may have been excluded from our analysis.
Third, Medicare Part A data only capture inpatient hospital
claims and procedures. Although it is unlikely that major
LE amputations are performed on an outpatient basis, the
association of revascularization procedures before amputa-
tion could not be assessed because of a shift from inpatient
vascular care to outpatient care. Finally, this analysis in-
cluded only those patients enrolled in fee-for-service Medi-
care, and the generalizability to all U.S. patients, including
non–fee-for-service Medicare beneficiaries, those with pri-
vate insurance, and younger patients, is unclear. However, it
should be noted that PAD is a disease of the elderly, a
Figure 2 Temporal Trends in Lower-Extremity Amputation by U.
Graph showing the temporal patterns of performance of LE amputation by U.S. Cepopulation most represented in Medicare.Conclusions
LE amputation rates have decreased significantly since 2000
in the United States. Significant geographic variation exists
in the performance of LE amputation in Medicare benefi-
ciaries with PAD. Future studies should aim to determine
the factors associated with the observed reduction in ampu-
tations and geographic variation. Finally, the current study
demonstrates the critical need for education programs for
clinicians and patients that will focus on best practices for the
prevention and treatment of PAD in patients at risk for LE
amputation nationwide.
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